Market Tracker

05/29 6:02pm ET

Novavax Inc (NASDAQ:NVAX)

9.00
Delayed Data
As of May 29
 +0.16 / +1.81%
Today’s Change
3.92
Today|||52-Week Range
9.95
+51.77%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close8.84
Today’s open8.82
Day’s range8.80 - 9.02
Volume2,945,570
Average volume (3 months)4,078,400
Market cap$2.4B
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)-19.35%
Earnings growth (this year)-18.87%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+46.59%
P/E ratioNM
Price/Sales43.68
Price/Book9.36

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...+2.16+2.05%
KITEKite Pharma Inc+2.59+4.93%
HALOHalozyme Therapeutic...-0.33-1.87%
RDUSRadius Health Inc+0.28+0.58%
Data as of 4:14pm ET, 05/29/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$30.7M
Annual profit (last year)-$82.9M
Net profit margin-270.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts